Combination productBiological
Biomarkers clinical trials
Keep track of what changes. Save the Biomarkers studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
- Biomarkers
- 2
Studies by the year they started
3 studies that test it; most in 2014 (1)
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2018 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 2
Tecnoquimicas (1) · Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1) · Ciusss de L'Est de l'Île de Montréal (1)
Studies
Open first, then newest update. How each study uses Biomarkers is read from its arms, and is right about nine times in ten.
Testing it · 3
- Characterization of Heart Failure With Preserved Ejection FractionRecruitingNot applicableCliniques universitaires Saint-Luc- Université Catholique de LouvainNCT03197350Written as biomarker
- Dorzolamide/Brimonidine/Timolol Impact on Ocular Surface, Glaucoma Progression & Chatbot Follow-up: GLAUCO-TECHActive, not recruitingPhase 4TecnoquimicasNCT07690397Written as Preservative-free dorzolamide-timolol-brimonidine combination
- Correlation Between NOL Index After Stimulus and Post-operative Opioid, Pain, Pre-operative PhenotypeTerminatedNot applicableCiusss de L'Est de l'Île de MontréalNCT03422783Written as Biomarkers
Codes
What other systems call Biomarkers · ClinicalTrials.gg INT008469
- MeSH (NLM) D015415BiomarkersOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D015415 | Biomarkers | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.